Latest Hydrocodone Stories
STAMFORD, Conn., April 29, 2014 /PRNewswire/ -- Purdue Pharma L.P.
SAN DIEGO, April 24, 2014 /PRNewswire/ -- We at Zogenix have reviewed the letter
SAN DIEGO, April 23, 2014 /PRNewswire/ -- Zogenix will continue to work to ensure patients suffering from severe chronic pain have access to the FDA-approved medications they need in every state
Codeine, or 3-methylmorphine, is an opioid that is used to treat mild to moderate pain and to suppress cough. While it is widely prescribed to adults, it is of great concern that US emergency rooms continue to prescribe it to children, despite its potentially harmful effects.
SAN DIEGO, April 15, 2014 /PRNewswire/ -- Zogenix, Inc.
SAN DIEGO, April 11, 2014 /PRNewswire/ -- Rampant misinformation about Zohydro(TM) ER continues to be reported by the media and echoed in Washington D.C. and some states' capitals.
SAN DIEGO, April 8, 2014 /PRNewswire/ -- Today Zogenix presented its case in U.S. District Court in Boston requesting an immediate order staying the ban on the U.S.
Company Files for Injunction - Prescription Drug Status Should Reside Solely With the FDA SAN DIEGO, April 7, 2014 /PRNewswire/ -- Zogenix, Inc.
Review of published literature points to need for physician monitoring, awareness of patient overuse of acetaminophen STAMFORD, Conn., April 4, 2014 /PRNewswire/ -- A review of published medical
SAN DIEGO, April 4, 2014 /PRNewswire/ -- Today, Health and Human Services (HHS) Secretary Kathleen Sebelius, and U.S. Food and Drug Administration (FDA) Commissioner Dr.